News Releases - Achieve Life Sciences

News Releases

Home 2017-06-16T21:39:52+00:00
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2020 Financial Results and Host Conference Call and Webcast on March 11, 2021

SEATTLE, Wash. and VANCOUVER, British Columbia / ACCESSWIRE / March 4, 2021 / Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that it will report its fourth quarter and year-end 2020 financial results and provide an update on the cytisinicline development program on Thursday, March 11, 2021 at 4:30PM ET.

To access the webcast, log on to the Investor Relations page of the Achieve website at http://ir.achievelifesciences.com/events-and-webcasts. Alternatively, you may access the live conference call by dialing (877) 472-9809 (U.S. & Canada) or (629) 228-0791 (International) and referencing conference ID 9395238. A webcast replay will be available approximately two hours after the call and will be archived on the website for 90 days. 

Investor Relations Contact 
Jason Wong 
jwong@bplifescience.com  
(415) 375-3340 ext. 4 

Media Contact
Glenn Silver
Glenn.Silver@Finnpartners.com
(646) 871-8485 

SOURCE: Achieve Life Sciences, Inc.

Stock Info